S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

ADVM Adverum Biotechnologies Inc

7.92

0.11 (1.41%)

01 Jun 2024 - Closed

Delayed by 15 minutes

Adverum plunges as analysts turn bearish citing setback for diabetic macular edema drug

To read the full story on Seeking Alpha, click here.

Adverum Biotechnologies (NASDAQ:ADVM)
Historical Stock Chart
From May 2024 to Jun 2024

Click Here for more Adverum Biotechnologies Charts.

Adverum Biotechnologies (NASDAQ:ADVM)
Historical Stock Chart
From Jun 2023 to Jun 2024

Click Here for more Adverum Biotechnologies Charts.

Adverum Biotechnologies Inc News

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Wednesday 29 May 2024 (4 days ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 10 May 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 10 May 2024 (3 weeks ago) • Edgar (US Regulatory)

Adverum Biotechnologies Reports First Quarter 2024 Financial Results and Provides Pipeline Highlights
Friday 10 May 2024 (3 weeks ago) • GlobeNewswire Inc.

Adverum Biotechnologies to Participate in Upcoming May Investor Conferences
Friday 3 May 2024 (4 weeks ago) • GlobeNewswire Inc.

Adverum Biotechnologies to Present LUNA 26-week Phase 2 Interim Analysis at the ASRS Annual Scientific Meeting
Friday 26 April 2024 (1 month ago) • GlobeNewswire Inc.

Adverum Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Pipeline Highlights and Corporate Updates
Tuesday 19 March 2024 (2 months ago) • GlobeNewswire Inc.

Form S-3 - Registration statement under Securities Act of 1933
Tuesday 5 March 2024 (3 months ago) • Edgar (US Regulatory)

Adverum Biotechnologies to Participate in the TD Cowen 44th Annual Health Care Conference
Thursday 29 February 2024 (3 months ago) • GlobeNewswire Inc.

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Friday 23 February 2024 (3 months ago) • Edgar (US Regulatory)

Form D - Notice of Exempt Offering of Securities
Thursday 22 February 2024 (3 months ago) • Edgar (US Regulatory)

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Friday 16 February 2024 (4 months ago) • Edgar (US Regulatory)

More Adverum Biotechnologies Inc News Articles

Defensive Equity Buywrit...

Graniteshares 3x Long Fa...

Great Plains Ethanol (GM)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions